2017
DOI: 10.4088/jcp.16m10831
|View full text |Cite
|
Sign up to set email alerts
|

Persistent Low Rates of Treatment of Metabolic Risk Factors in People With Psychotic Disorders

Abstract: Metabolic risk factors are still seriously undertreated in people with psychotic disorders. Better adherence to and better implementation of guidelines about monitoring and treating metabolic disorders in psychiatry are crucial.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
22
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
2
1

Relationship

2
8

Authors

Journals

citations
Cited by 26 publications
(26 citation statements)
references
References 39 publications
3
22
1
Order By: Relevance
“…In total 42.8% of all patients with a diagnosis in the psychosis spectrum in care at four mental healthcare institutions participated in the PHAMOUS study in the year VICTROM was added [31]. Of this group 65.9% (n = 581) completed the victimization survey during the 9-months study period.…”
Section: Resultsmentioning
confidence: 99%
“…In total 42.8% of all patients with a diagnosis in the psychosis spectrum in care at four mental healthcare institutions participated in the PHAMOUS study in the year VICTROM was added [31]. Of this group 65.9% (n = 581) completed the victimization survey during the 9-months study period.…”
Section: Resultsmentioning
confidence: 99%
“…However, it was beyond the scope of this study to ascertain the rate of follow-up actions. Therefore, a future study is now required to demonstrate that the HIP-F has utility beyond establishing risk factors/recommending actions, i.e., that it results in actual changes in patients' behaviour, treatment and physical health state [72]. Therefore, in order to more conclusively demonstrate the clinical utility and efficacy of the HIP-F, future prospective studies should compare the outcomes of patients who have completed the HIP-F with those engaged in treatment as usual using a randomised controlled clinical trial.…”
Section: Discussionmentioning
confidence: 99%
“…Body Mass Index (BMI), blood pressure, estimated Glomerular Filtration Rate (eGFR), smoking status, fasting glucose, lipid spectrum, use of alcohol, family history of cardiovascular disease) [ 43 ]. However, considering the observational nature of this study and screening criteria described in previous studies [ 29 , 30 ], we included a broader range of assessments (Additional file 1 : Appendix A1).…”
Section: Methodsmentioning
confidence: 99%